v3.26.1
Contingent Liabilities And Commitments (Details)
 12 Months Ended
Jan. 01, 2024
USD ($)
Jun. 30, 2023
USD ($)
shares
Jul. 27, 2022
USD ($)
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2025
ILS (₪)
shares
Mar. 31, 2025
$ / shares
Mar. 05, 2025
$ / shares
shares
Dec. 31, 2024
shares
May 31, 2024
$ / shares
May 01, 2024
$ / shares
Sep. 30, 2023
shares
Jan. 31, 2023
shares
Contingent Liabilities And Commitments [Line Items]                        
Total cost description       The total cost of the new study will be $800 + $160 (overhead) + VAT (which consist of $700 + VAT pre-clinical lab research cost, $120 + VAT Mouse model for systemic inflammation and $140 + VAT Mouse model for Rheumatoid Arthritis).                
Accrued interest       $ 297,700 ₪ 949,700              
Cash payment | $       $ 100,000                
Percentage of royalty fee       15.00%                
Common stock, shares, issued (in Shares) | shares       20,176,418 20,176,418     18,701,418        
Cost of services | $   $ 200,000 $ 100,000                  
Warrants share (in Shares) | shares       1,000,000 1,000,000              
Exercise price per share (in Dollars per share) | $ / shares           $ 2.5            
Termination fee | $       $ 360,000                
Net royalty’s income percent       15.00%                
Service Agreement [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Reimburse expense | $       $ 12,000                
Mr. Ofir [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Termination fee | $       $ 120,000                
Dr. Hayon [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Warrants share (in Shares) | shares       350,000 350,000              
Exercise price per share (in Dollars per share) | $ / shares       $ 0.01                
Dr. Igal Louria Hayon [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Exercise price per share (in Dollars per share) | $ / shares                   $ 0.01    
Way of Life Cannabis Ltd [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Percentage of share capital issued       3.00% 3.00%              
Percentage of share capital outstanding       3.00% 3.00%              
Common stock, shares, issued (in Shares) | shares   201,000 100,500                  
Chief Executive Officer [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Monthly fee | $ $ 20,000                      
Warrants share (in Shares) | shares       350,000 350,000              
CFO [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Monthly fee | $       $ 12,000                
Granted shares (in Shares) | shares       1,000,000                
Chief Technology Officer [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Reimburse expense | $       $ 24,000                
Common Stock [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Common stock, shares, issued (in Shares) | shares                     1,454,250 255,750
Exercise price per share (in Dollars per share) | $ / shares                 $ 0.01      
Exercise price (in Dollars per share) | $ / shares       $ 1                
Common Stock [Member] | Mr. Pilo [Member]                        
Contingent Liabilities And Commitments [Line Items]                        
Warrants share (in Shares) | shares             1,000,000          
Exercise price per share (in Dollars per share) | $ / shares             $ 1.12